Display options
Share it on
Full text links
Wolters Kluwer Free PMC Article

Ann Surg. 1991 Aug;214(2):155-67. doi: 10.1097/00000658-199108000-00010.

Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts.

Annals of surgery

K L Yun, J I Fann, M H Sokoloff, L G Fong, G E Sarris, M E Billingham, D C Miller

Affiliations

  1. Department of Cardiovascular Surgery, Stanford University School of Medicine, California.

PMID: 1867523 PMCID: PMC1358515 DOI: 10.1097/00000658-199108000-00010
Free PMC Article

Abstract

With the advent of cyclosporin A, accelerated coronary arteriosclerosis has become the major impediment to the long-term survival of heart transplant recipients. Due to epidemiologic reports suggesting a salutary effect of fish oil, the dose response of fish oil on graft coronary arteriosclerosis in a rabbit heterotopic cardiac allograft model was assessed using safflower oil as a caloric control. Seven groups of New Zealand White rabbits (n = 10/group) received heterotropic heart transplants from Dutch-Belted donors and were immunosuppressed with low-dose cyclosporin A (7.5 mg/kg/day). Group 1 animals were fed a normal diet and served as control. Group 2, 3, and 4 animals received a daily supplement of low- (0.25 mL/kg/day), medium- (0.75 mL/kg/day), and high- (1.5 mL/kg/day) dose fish oil (116 mg n-3 polyunsaturated fatty acid/mL), respectively. Group 5, 6, and 7 animals were supplemented with equivalent dose of safflower oil (i.e., 0.25, 0.75, and 1.5 mL/kg/day). Oil-supplemented rabbits were pretreated for 3 weeks before transplantation and maintained on the same diet for 6 weeks after operation. The extent of graft coronary arteriosclerosis was quantified using computer-assisted, morphometric planimetry. When the animals were killed, cyclosporin A was associated with elevated plasma total cholesterol and triglyceride levels in the control group. While safflower oil prevented the increase in plasma lipids at all dosages, fish oil ameliorated the cyclosporin-induced increase in total cholesterol only with high doses. Compared to control animals, there was a trend for more graft vessel disease with increasing fish oil dose, as assessed by mean luminal occlusion and intimal thickness. A steeper trend was observed for increasing doses of safflower oil; compared to the high-dose safflower oil group, animals supplemented with low-dose safflower oil had less mean luminal occlusion (16.3% +/- 5.9% versus 41.4% +/- 7.6%, p less than 0.017) and intimal thickness (7.9 +/- 1.9 microns versus 34.0 +/- 13.0 microns, analysis of variance: p = 0.054). Low-dose safflower oil also had a slight, but nonsignificant, beneficial effect on graft vessel disease when compared to control rabbits. The same trends were observed in the degree of histologic rejection (0 = none to 3 = severe) in fish oil- and safflower oil-treated animals. Rejection score correlated weakly but significantly (p = 0.0001) with mean luminal occlusion (r = 0.52) and intimal thickness (r = 0.46). Therefore allograft coronary disease in this model appeared to exhibit an unfavorable, direct-dose response to fish oil and safflower oil, independent of effects on plasma lipids.(ABSTRACT TRUNCATED AT 400 WORDS)

Similar articles

Show all 7 similar articles

References

  1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  2. N Engl J Med. 1989 Apr 6;320(14):915-24 - PubMed
  3. Atherosclerosis. 1988 Jul;72(1):29-35 - PubMed
  4. Arteriosclerosis. 1989 Mar-Apr;9(2):189-94 - PubMed
  5. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1372-6 - PubMed
  6. Arteriosclerosis. 1989 Jul-Aug;9(4):529-37 - PubMed
  7. J Am Coll Cardiol. 1988 Oct;12(4):1073-8 - PubMed
  8. Arteriosclerosis. 1988 May-Jun;8(3):281-7 - PubMed
  9. Proc Natl Acad Sci U S A. 1987 May;84(9):2995-8 - PubMed
  10. Atherosclerosis. 1987 Jan;63(1):53-6 - PubMed
  11. Immunol Lett. 1985;11(5-6):343-9 - PubMed
  12. Atherosclerosis. 1987 Nov;68(1-2):95-103 - PubMed
  13. Arteriosclerosis. 1987 Sep-Oct;7(5):441-9 - PubMed
  14. N Engl J Med. 1988 Mar 3;318(9):549-57 - PubMed
  15. Transplantation. 1988 Mar;45(3):614-7 - PubMed
  16. Lancet. 1985 May 4;1(8436):999-1002 - PubMed
  17. Arteriosclerosis. 1987 Jan-Feb;7(1):55-60 - PubMed
  18. N Engl J Med. 1986 Apr 10;314(15):937-42 - PubMed
  19. Arteriosclerosis. 1988 Jan-Feb;8(1):79-87 - PubMed
  20. J Vasc Surg. 1988 Jan;7(1):108-18 - PubMed
  21. Transplantation. 1987 Dec;44(6):838-9 - PubMed
  22. JAMA. 1987 Dec 4;258(21):3142-5 - PubMed
  23. Circulation. 1987 Nov;76(5 Pt 2):V56-61 - PubMed
  24. N Engl J Med. 1987 Oct 1;317(14):861-6 - PubMed
  25. Transplant Proc. 1987 Aug;19(4 Suppl 5):19-25 - PubMed
  26. Lab Invest. 1986 Oct;55(4):455-62 - PubMed
  27. J Biol Chem. 1987 May 5;262(13):6046-54 - PubMed
  28. Arteriosclerosis. 1986 Sep-Oct;6(5):505-10 - PubMed
  29. N Engl J Med. 1986 Oct 2;315(14):841-6 - PubMed
  30. J Heart Transplant. 1988 May-Jun;7(3):171-5 - PubMed
  31. Surgery. 1988 Aug;104(2):343-9 - PubMed
  32. JAMA. 1988 Aug 5;260(5):665-70 - PubMed
  33. J Thorac Cardiovasc Surg. 1989 Jun;97(6):841-54; discussion 854-5 - PubMed
  34. Cardiovasc Res. 1989 Jul;23(7):631-8 - PubMed
  35. N Engl J Med. 1989 Feb 2;320(5):265-71 - PubMed
  36. Transplant Proc. 1987 Feb;19(1 Pt 2):1820-1 - PubMed
  37. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9748-52 - PubMed
  38. Ann Surg. 1988 Dec;208(6):746-54 - PubMed
  39. Transplantation. 1988 Nov;46(5):722-5 - PubMed
  40. Science. 1988 Jul 22;241(4864):453-6 - PubMed
  41. Ann Thorac Surg. 1986 Jan;41(1):54-7 - PubMed
  42. Can J Surg. 1985 May;28(3):274-80, 282 - PubMed
  43. Transplant Proc. 1985 Aug;17(4):1997-2002 - PubMed
  44. Transplantation. 1985 Apr;39(4):385-8 - PubMed
  45. N Engl J Med. 1985 May 9;312(19):1205-9 - PubMed
  46. Arteriosclerosis. 1984 May-Jun;4(3):196-207 - PubMed
  47. Circulation. 1983 Sep;68(3 Pt 2):II94-101 - PubMed
  48. J Clin Immunol. 1983 Oct;3(4):295-315 - PubMed
  49. Nature. 1984 Jan 12-18;307(5947):165-8 - PubMed
  50. Nature. 1982 Sep 9;299(5879):163-5 - PubMed
  51. Thromb Res. 1983 Nov 15;32(4):373-9 - PubMed
  52. Kidney Int. 1983 Mar;23(3):506-13 - PubMed
  53. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883-7 - PubMed
  54. Arteriosclerosis. 1984 Jul-Aug;4(4):357-64 - PubMed
  55. Arteriosclerosis. 1983 May-Jun;3(3):215-22 - PubMed
  56. Arteriosclerosis. 1983 Mar-Apr;3(2):149-59 - PubMed
  57. Transplantation. 1981 Dec;32(6):488-9 - PubMed
  58. Transplant Proc. 1981 Mar;13(1 Pt 1):207-11 - PubMed
  59. Clin Chem. 1982 Jun;28(6):1379-88 - PubMed
  60. Proc Natl Acad Sci U S A. 1979 Feb;76(2):944-8 - PubMed
  61. Thromb Haemost. 1978 Apr 30;39(2):304-11 - PubMed
  62. Lancet. 1971 Jun 5;1(7710):1143-5 - PubMed
  63. Arch Pathol. 1972 Mar;93(3):240-5 - PubMed
  64. Z Klin Chem Klin Biochem. 1974 May;12(5):226 - PubMed
  65. Clin Chem. 1974 Apr;20(4):470-5 - PubMed
  66. Transplant Proc. 1971 Mar;3(1):512-4 - PubMed
  67. Circulation. 1970 May;41(5):753-72 - PubMed
  68. Proc Natl Acad Sci U S A. 1976 Mar;73(3):928-31 - PubMed
  69. Clin Chem. 1975 Dec;21(13):1983-5 - PubMed
  70. J Clin Invest. 1986 Mar;77(3):757-61 - PubMed
  71. J Surg Res. 1986 Jan;40(1):6-12 - PubMed
  72. N Engl J Med. 1985 May 9;312(19):1217-24 - PubMed
  73. J Clin Invest. 1985 Oct;76(4):1626-31 - PubMed
  74. J Biol Chem. 1985 Sep 15;260(20):10966-70 - PubMed
  75. Am J Cardiol. 1988 Dec 1;62(17):1268-72 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources